These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 21861052)
1. [Activation of hippocampal D1 dopamine receptor inhibits glutamate-mediated depression induced by chronic unpredictable mild stress in rats]. Yuan TT; Qiao H; Dong SP; An SC Sheng Li Xue Bao; 2011 Aug; 63(4):333-41. PubMed ID: 21861052 [TBL] [Abstract][Full Text] [Related]
2. [Involvement of hippocampal NMDA receptor and neuropeptide Y in depression induced by chronic unpredictable mild stress]. Yu L; An SC; Lian T Sheng Li Xue Bao; 2010 Feb; 62(1):14-22. PubMed ID: 20179883 [TBL] [Abstract][Full Text] [Related]
3. [Modulation of hippocampal glutamate and NMDA/AMPA receptor by homocysteine in chronic unpredictable mild stress-induced rat depression]. Liu H; Wen LM; Qiao H; An SC Sheng Li Xue Bao; 2013 Feb; 65(1):61-71. PubMed ID: 23426515 [TBL] [Abstract][Full Text] [Related]
4. Synergistic interactions of dopamine D1 and glutamate NMDA receptors in rat hippocampus and prefrontal cortex: involvement of ERK1/2 signaling. Sarantis K; Matsokis N; Angelatou F Neuroscience; 2009 Nov; 163(4):1135-45. PubMed ID: 19647050 [TBL] [Abstract][Full Text] [Related]
5. [Hippocampus quinolinic acid modulates glutamate and NMDAR/mGluR1 in chronic unpredictable mild stress-induced depression]. Chen HB; Li F; Wu S; An SC Sheng Li Xue Bao; 2013 Dec; 65(6):577-85. PubMed ID: 24343714 [TBL] [Abstract][Full Text] [Related]
6. [The association of hippocampal glutamate with depression and the effects on gastric mobility]. Wang MH; An SC Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2009 May; 25(2):196-201. PubMed ID: 21189550 [TBL] [Abstract][Full Text] [Related]
7. Role of NMDA and AMPA glutamate receptors in the induction and the expression of dopamine-mediated sensitization in 6-hydroxydopamine-lesioned rats. Pollack AE; St Martin JL; MacPherson AT Synapse; 2005 Apr; 56(1):45-53. PubMed ID: 15700284 [TBL] [Abstract][Full Text] [Related]
8. Sustained enhancement of AMPA receptor- and NMDA receptor-mediated currents induced by dopamine D1/D5 receptor activation in the hippocampus: an essential role of postsynaptic Ca2+. Yang SN Hippocampus; 2000; 10(1):57-63. PubMed ID: 10706217 [TBL] [Abstract][Full Text] [Related]
9. Evidence for involvement of brain dopamine and other mechanisms in the behavioral action of the N-methyl-D-aspartic acid antagonist MK-801 in control and 6-hydroxydopamine-lesioned rats. Criswell HE; Johnson KB; Mueller RA; Breese GR J Pharmacol Exp Ther; 1993 May; 265(2):1001-10. PubMed ID: 8098756 [TBL] [Abstract][Full Text] [Related]
10. Differential expression of NMDA and AMPA receptor subunits in rat dorsal and ventral hippocampus. Pandis C; Sotiriou E; Kouvaras E; Asprodini E; Papatheodoropoulos C; Angelatou F Neuroscience; 2006 Jun; 140(1):163-75. PubMed ID: 16542781 [TBL] [Abstract][Full Text] [Related]
11. Differential interaction of competitive NMDA and AMPA antagonists with selective dopamine D-1 and D-2 agonists in a rat model of Parkinson's disease. Löschmann PA; Wüllner U; Heneka MT; Schulz JB; Kunow M; Wachtel H; Klockgether T Synapse; 1997 Aug; 26(4):381-91. PubMed ID: 9215597 [TBL] [Abstract][Full Text] [Related]
12. Failure of MK-801 to suppress D1 receptor-mediated induction of locomotor activity and striatal preprotachykinin mRNA expression in the dopamine-depleted rat. Campbell BM; Kreipke CW; Walker PD Neuroscience; 2006; 137(2):505-17. PubMed ID: 16289829 [TBL] [Abstract][Full Text] [Related]
13. Impact of metyrapone on MK-801-induced alterations in the rat dopamine D1 receptors. Czyrak A; Maćkowiak M; Fijał K; Chocyk A; Wedzony K Pol J Pharmacol; 1997; 49(5):305-16. PubMed ID: 9566029 [TBL] [Abstract][Full Text] [Related]
14. Exposure to novel environment is characterized by an interaction of D1/NMDA receptors underlined by phosphorylation of the NMDA and AMPA receptor subunits and activation of ERK1/2 signaling, leading to epigenetic changes and gene expression in rat hippocampus. Sarantis K; Antoniou K; Matsokis N; Angelatou F Neurochem Int; 2012 Jan; 60(1):55-67. PubMed ID: 22080157 [TBL] [Abstract][Full Text] [Related]
15. Differential effects of NMDA and AMPA/kainate receptor antagonists on nitric oxide production in rat brain following intrahippocampal injection. Radenovic L; Selakovic V Brain Res Bull; 2005 Sep; 67(1-2):133-41. PubMed ID: 16140172 [TBL] [Abstract][Full Text] [Related]
16. Glutamate-stimulated release of norepinephrine in hippocampal slices of animal models of attention-deficit/hyperactivity disorder (spontaneously hypertensive rat) and depression/anxiety-like behaviours (Wistar-Kyoto rat). Howells FM; Russell VA Brain Res; 2008 Mar; 1200():107-15. PubMed ID: 18295191 [TBL] [Abstract][Full Text] [Related]
17. [Antidepressant effect of microinjection of neuropeptide Y into the hippocampus is mediated by decreased expression of nitric oxide synthase]. Lian T; An SC Sheng Li Xue Bao; 2010 Jun; 62(3):237-46. PubMed ID: 20571741 [TBL] [Abstract][Full Text] [Related]
19. MK-801 alters the effects of priming with L-DOPA on dopamine D1 receptor-induced changes in neuropeptide mRNA levels in the rat striatal output neurons. Van De Witte SV; Groenewegen HJ; Voorn P Synapse; 2002 Jan; 43(1):1-11. PubMed ID: 11746728 [TBL] [Abstract][Full Text] [Related]
20. Comparing long-term depression with pharmacologically induced synaptic attenuations in young rat hippocampi. Xiao MY; Niu YP; Wigstrom H Synapse; 1997 Aug; 26(4):329-40. PubMed ID: 9215592 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]